Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response

Open access

Published version of a preprint

Abstract

Here, we report that genome editing by CRISPR-Cas9 induces a p53-mediated DNA damage response and cell cycle arrest in immortalized human retinal pigment epithelial cells, leading to a selection against cells with a functional p53 pathway. Inhibition of p53 prevents the damage response and increases the rate of homologous recombination from a donor template. These results suggest that p53 inhibition may improve the efficiency of genome editing of untransformed cells and that p53 function should be monitored when developing cell-based therapies utilizing CRISPR-Cas9.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0049-z

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 2

  1. Lee, K. et al. eLife 6, e25312 (2017).
  2. Luo, M. & Chen, Y. Int. J. Ophthalmol. 11, 150–159 (2018).

Cited by

See all 1,264

Metadata

Authors
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., & Taipale, J.
Affiliations
  • University of Helsinki (FI)
  • Karolinska Institutet (SE)
Corresponding author
  • Schmierer, Bernhard
  • Taipale, Jussi
Venue
Nature Medicine
Published
2018-06-11
Volume
24
Issue
7
Pages
927-930
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2806820493
Cited by
1,264
References
27
Citations by year
2026: 128 · 2025: 133 · 2024: 151 · 2023: 146 · 2022: 143 · 2021: 150 · 2020: 170 · 2019: 162 · 2018: 81
FWCI
50.96
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
Funders
  • Academy of Finland
  • Cancerfonden
  • Karolinska Institutet
  • Knut och Alice Wallenbergs Stiftelse
  • Science for Life Laboratory
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
CRISPR/Cas9 genome editing, p53, DNA damage response, cell cycle arrest, retinal pigment epithelial cells, homologous recombination, p53 inhibition, cell therapy, off-target effects
MeSH terms
Gene Editing, CRISPR-Associated Protein 9, Cell Cycle, DNA Damage, Humans, Ribonucleoproteins, Tumor Suppressor Protein p53, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p21, HEK293 Cells, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. https://app.cochat.ai/papers/10.1038/s41591-018-0049-z
The paper
Haapaniemi, E., Botla, S., Persson, J., Schmierer, B., & Taipale, J. (2018). CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response. Nature Medicine. https://doi.org/10.1038/s41591-018-0049-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.